RFID组织扩张器两阶段乳房再造扩张期并发症的多中心风险预测模型与列线图
本研究基于356例使用RFID组织扩张器行两阶段乳房再造的患者,建立扩张期并发症预测模型。平均随访29.4个月,并发症发生率21.6%,最常见为血清肿(7.8%)。年龄>50岁、吸烟和放疗为独立危险因素,胸肌下囊袋为保护因素,模型AUC为0.698,风险评分可区分低危(8.7%)和高危(39.0%)组。
要点
- 年龄>50岁、吸烟、放疗增加扩张期并发症风险,胸肌下囊袋降低风险。
- 基于0-9分风险评分可个体化预估并发症风险,低危组8.7%,高危组39.0%。
- 模型AUC为0.698,校准可接受,需进一步内外部验证。
核心结论
- 年龄>50岁、吸烟和放疗是RFID组织扩张器两阶段乳房再造扩张期并发症的独立危险因素,胸肌下囊袋为保护因素。
- 基于上述因素构建的0-9分风险评分可区分低危和高危患者,辅助术前个体化风险评估。
研究设计与样本
- 多中心队列研究,纳入356例使用RFID组织扩张器行两阶段乳房再造的患者。
- 主要终点为扩张期术后总体并发症,采用多变量逻辑回归筛选独立预测因素。
- 模型性能通过ROC分析和Hosmer-Lemeshow检验评估,回归系数转换为整数风险评分。
主要发现
- 平均随访29.4±16.6个月,并发症发生率为21.6%,最常见为血清肿(7.8%)。
- 独立预测因素包括年龄>50岁(OR: 2.25)、吸烟(OR: 2.00)和放疗(OR: 2.26),胸肌下囊袋为保护因素(OR: 0.44)。
- 风险评分AUC为0.698(95% CI: 0.628-0.768; p<0.001),校准检验p=0.051。
- 低危组和高危组并发症发生率分别为8.7%和39.0%(p<0.001)。
关键数值与推荐
- 风险评分范围为0-9分,基于年龄>50岁、吸烟、放疗和胸肌下囊袋四个变量。
- 模型AUC为0.698(95% CI: 0.628-0.768; p<0.001),Hosmer-Lemeshow检验p=0.051。
临床怎么用
- 术前可依据年龄、吸烟史、放疗史和计划囊袋位置计算风险评分,识别高危患者并优化手术规划。
- 对高危患者可考虑选择胸肌下囊袋、加强围手术期戒烟干预和放疗后管理。
局限性
- 模型为初步推导,需内部和外部验证。
- 样本量有限,随访时间尚不足以评估长期结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-stage implant-based breast reconstruction (TSBR) using tissue expanders (TE) continues to be a standard procedure. Although TE incorporating non-metallic radiofrequency identification (RFID) ports have been introduced to address the limitations of metallic systems, clinical data are limited, and no validated models exist to guide individualized surgical planning. OBJECTIVE: To develop a clinical prediction model and risk score for complications during RFID-TE reconstruction. METHODS: We conducted a multicenter cohort study involving 356 patients undergoing TSBR with RFID-enabled TE. The primary endpoint was overall postoperative complications during the expander phase. Candidate predictors included demographic and treatment-related variables. Independent predictors were identified using multivariable logistic regression. Model performance was assessed using receiver operating characteristic (ROC) analysis and Hosmer-Lemeshow testing. Regression coefficients were converted into an integer-based score to improve risk stratification. RESULTS: At a mean follow-up of 29.4±16.6 months, complications, most commonly seroma (7.8%), occurred in 21.6% of the patients. Independent predictors of complications included age >50 years (OR: 2.25 years), smoking (OR: 2.00), and radiation therapy (OR: 2.26), whereas use of the submuscular pocket was protective (OR: 0.44). These variables were incorporated into a 0-9 point risk score, which yielded an area under the ROC curve of 0.698 (95% CI: 0.628-0.768; p<0.001), with acceptable calibration (p=0.051). Risk stratification demonstrated complication rates of 8.7 and 39.0% in the low- and high-risk groups, respectively (p<0.001), enabling individualized estimation of expander-phase complication risk during preoperative planning. CONCLUSION: This study derives the first prediction model specific to RFID-TE reconstruction. By translating independent predictors into a preliminary risk score, the model provides a framework for individualized risk stratification and basis for future internal and external validation.
引用
- Munhoz AM, Tejerina A, Ruano AG, et al. Expander-phase morbidity in RFID-enabled two-stage breast reconstruction: A multicenter risk prediction model and clinical nomogram. J Plast Reconstr Aesthet Surg. 2026. PMID: 42887059. doi:10.1016/j.bjps.2026.09.054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。